Fort Lee, NJ, United States of America

Zhong Wu


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):

Title: Innovations in Immunotherapy by Zhong Wu

Introduction

Zhong Wu is a notable inventor based in Fort Lee, NJ (US). He has made significant contributions to the field of immunotherapy, particularly in the treatment of hepatocellular carcinoma. His innovative approach has the potential to improve outcomes for patients suffering from this challenging condition.

Latest Patents

Zhong Wu holds a patent for a method aimed at the prevention, delay of progression, or treatment of hepatocellular carcinoma. This patent, which involves administering a therapeutically effective amount of an anti-PD-1 antibody, specifically targets human PD-1. His work in this area is crucial for advancing cancer treatment options.

Career Highlights

Zhong Wu is currently associated with BeiGene, Ltd., a company known for its focus on molecularly targeted and immuno-oncology drug discovery. His role at BeiGene allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of Zhong Wu's notable coworkers include Lai Wang and Kang Li. Their combined expertise enhances the research environment and fosters innovation within the company.

Conclusion

Zhong Wu's contributions to immunotherapy represent a significant advancement in the fight against hepatocellular carcinoma. His innovative methods and collaboration with esteemed colleagues position him as a key figure in the ongoing development of effective cancer treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…